Atlas Brown Inc. Cuts Stock Holdings in CVS Health Co. (NYSE:CVS)

Atlas Brown Inc. cut its stake in CVS Health Co. (NYSE:CVS) by 9.4% in the fourth quarter, HoldingsChannel reports. The firm owned 4,751 shares of the pharmacy operator’s stock after selling 492 shares during the quarter. Atlas Brown Inc.’s holdings in CVS Health were worth $213,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health during the third quarter worth about $25,000. Ridgewood Investments LLC increased its position in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the 3rd quarter worth $31,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health during the third quarter worth $31,000. Finally, Reston Wealth Management LLC acquired a new stake in CVS Health in the third quarter valued at $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the company. Mizuho dropped their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a report on Thursday, October 24th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. TD Cowen lifted their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Tuesday, October 1st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Price Performance

Shares of CVS Health stock traded up $2.00 on Friday, hitting $48.01. The company’s stock had a trading volume of 13,614,145 shares, compared to its average volume of 12,717,844. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a fifty day moving average price of $51.98 and a 200-day moving average price of $56.68. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a market capitalization of $60.42 billion, a P/E ratio of 12.19, a price-to-earnings-growth ratio of 0.85 and a beta of 0.59.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. During the same period last year, the company posted $2.21 EPS. The company’s revenue was up 6.3% on a year-over-year basis. On average, equities research analysts expect that CVS Health Co. will post 5.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 5.54%. The ex-dividend date is Thursday, January 23rd. CVS Health’s dividend payout ratio is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.